BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21435463)

  • 21. Overexpression of telomerase-associated chaperone proteins in prostatic intraepithelial neoplasia and carcinomas.
    Elmore LW; Forsythe R; Forsythe H; Bright AT; Nasim S; Endo K; Holt SE
    Oncol Rep; 2008 Sep; 20(3):613-7. PubMed ID: 18695913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells.
    Armakolas A; Philippou A; Panteleakou Z; Nezos A; Sourla A; Petraki C; Koutsilieris M
    Prostate; 2010 Aug; 70(11):1233-42. PubMed ID: 20564425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ETV4 promotes late development of prostatic intraepithelial neoplasia and cell proliferation through direct and p53-mediated downregulation of p21.
    Cosi I; Pellecchia A; De Lorenzo E; Torre E; Sica M; Nesi G; Notaro R; De Angioletti M
    J Hematol Oncol; 2020 Aug; 13(1):112. PubMed ID: 32791988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
    Sroka IC; McDaniel K; Nagle RB; Bowden GT
    Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced annexin II protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yee DS; Narula N; Ramzy I; Boker J; Ahlering TE; Skarecky DW; Ornstein DK
    Arch Pathol Lab Med; 2007 Jun; 131(6):902-8. PubMed ID: 17550317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis.
    Xie Y; Yan J; Cutz JC; Rybak AP; He L; Wei F; Kapoor A; Schmidt VA; Tao L; Tang D
    Biochim Biophys Acta; 2012 Jun; 1822(6):875-84. PubMed ID: 22406297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
    Wong YC; Xie W; Tsao SW
    Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
    Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
    Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer.
    Varambally S; Laxman B; Mehra R; Cao Q; Dhanasekaran SM; Tomlins SA; Granger J; Vellaichamy A; Sreekumar A; Yu J; Gu W; Shen R; Ghosh D; Wright LM; Kladney RD; Kuefer R; Rubin MA; Fimmel CJ; Chinnaiyan AM
    Neoplasia; 2008 Nov; 10(11):1285-94. PubMed ID: 18953438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of NSAID-activated gene product in prostate cancer.
    Iczkowski KA; Pantazis CG
    Int J Surg Pathol; 2003 Jul; 11(3):159-66. PubMed ID: 12894347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma.
    Yang Y; Hao J; Liu X; Dalkin B; Nagle RB
    Am J Pathol; 1997 Feb; 150(2):693-704. PubMed ID: 9033282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Pan CX; Kinch MS; Kiener PA; Langermann S; Serrero G; Sun L; Corvera J; Sweeney CJ; Li L; Zhang S; Baldridge LA; Jones TD; Koch MO; Ulbright TM; Eble JN; Cheng L
    Clin Cancer Res; 2004 Feb; 10(4):1333-7. PubMed ID: 14977833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
    Zeng L; Rowland RG; Lele SM; Kyprianou N
    Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of MSX2 in nodular hyperplasia, high-grade prostatic intraepithelial neoplasia and prostate adenocarcinoma.
    Chua CW; Chiu YT; Yuen HF; Chan KW; Wang X; Ling MT; Wong YC
    APMIS; 2010 Dec; 118(12):918-26. PubMed ID: 21091772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.